INFECTIOUS DISEASES INSTITUTE

+256700158237/0800200055 training@idi.co.ug
Showing 221-230 of 516 items.
#Activity TitleCPD ProviderStart DateEvent TimeLocationCost (UGX)CPD PointsEnd DateStatusDetails
221Switch MeetingINFECTIOUS DISEASES INSTITUTEJul 23, 202409:00 AMHybrid01Jul 23, 2024ClosedRead More
222Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trialINFECTIOUS DISEASES INSTITUTEJul 22, 202409:00 AMzoom01Jul 22, 2024ClosedRead More
223A 52 year old female with a 4/2 history of generalised body weakness, dizzness and difficulty in walkingINFECTIOUS DISEASES INSTITUTEJul 19, 202409:15 AMHybrid01Jul 19, 2024ClosedRead More
224Approach to a patient with CMV in HIVINFECTIOUS DISEASES INSTITUTEJul 12, 202409:00 AMHybrid01Jul 12, 2024ClosedRead More
225Switch MeetingINFECTIOUS DISEASES INSTITUTEJul 2, 202409:00 AMhybrid01Jul 2, 2024ClosedRead More
226Switch MeetingINFECTIOUS DISEASES INSTITUTEJul 1, 202403:45 PMHybrid01Jul 1, 2024ClosedRead More
227Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trialINFECTIOUS DISEASES INSTITUTEJul 1, 202408:45 AMHybrid01Jul 1, 2024ClosedRead More
228Case discussionINFECTIOUS DISEASES INSTITUTEJun 28, 202408:45 AMHybrid01Jun 28, 2024ClosedRead More
229HIV viral load suppression following intensive adherence counseling among people living with HIV on treatment at military-managed health facilities in UgandaINFECTIOUS DISEASES INSTITUTEJun 24, 202408:30 AMTraining Room 2&301Jun 24, 2024ClosedRead More
230A 62 year newly diagnosed HIV/AIDS male with loss of visionINFECTIOUS DISEASES INSTITUTEJun 21, 202408:45 AMHybrid01Jun 21, 2024ClosedRead More